syngene and its peer biocon both showing signs of one side upmove
the stock looks great at cmp for a 15 % up-move to the least
it was into a deep consolidation.
from a good amount of time
the best part about this time is it gave a good spike rejection and that too at lower ends of the box
although sl should be respected
the stock looks great at cmp for a 15 % up-move to the least
it was into a deep consolidation.
from a good amount of time
the best part about this time is it gave a good spike rejection and that too at lower ends of the box
although sl should be respected